Logo-aim
Arch Iran Med. 2023;26(11): 647-653. doi: 10.34172/aim.2023.95
PMID: 38310425        PMCID: PMC10864943

Original Article

Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study

Abdorreza Naser Moghadasi 1 * ORCID, Fereshteh Ashtari 2, Seyed Mohammad Baghbanian 3, Vahid Shaygannejad 2, Nassim Anjidani 4, Fereshteh Ghadiri 1, Behnaz Sedighi 5, Morteza Saeidi 6, Hamed Amirifard 7, Hormoz Ayromlou 8, Nahid Beladi Moghadam 9, Mohammad Bagher Ranjbar 10, Masoume Nazeri 11, Zahra Niknam 12, Fardin Faraji 13, Afsaneh Afsorde 14, Mohammad Ali Sahraian 1 ORCID

Cited by CrossRef: 0


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.